delayed therapy

Mesothelioma, a rare cancer linked to asbestos, poses treatment challenges. A new study asks if immediate total therapy is always best for these patients. The study was published in Clinical Lung Cancer. It looks at patients with inoperable pleural mesothelioma. It focuses on those who received immediate treatment or chose to wait before starting therapy. Immediate vs. Deferred Treatment: Understanding the Choices Traditionally, platinum-based chemotherapy has been the standard first-line treatment for inoperable mesothelioma. However, emerging therapies, such as immunotherapy combinations, are changing the treatment landscape. These advancements happened alongside the 2018 American Society of Clinical Oncology (ASCO) guideline. It proposed caution for asymptomatic patients with low disease burden. It suggested they consider a trial of expectant observation before starting…